Originally posted here.
Medicines360 announced that Avibela™, a 52 mg levonorgestrel intrauterine device (IUD), has launched in Zambia! AVIBELA is the first hormonal IUD registered in Zambia. AVIBELA is not indicated for use in the United States.
Through the global FP2020 initiative, the Zambian government has committed to improving sustainable access to family planning. In alignment with this goal, the Society for Family Health Zambia, a network partner of Population Services International (PSI), provides AVIBELA at no cost to women in public sector clinics. The product is available in Luapula Province, and will soon be available to clinics in other provinces.
In Zambia, 22% of married women have an unmet need for modern contraception. Medicines360 is thrilled to give Zambian women access to another long-acting, reversible contraceptive option. According to Ashley Jackson, Deputy Director for the USAID-funded Expanding Effective Contraceptive Options project at PSI, “Emerging evidence suggests that for many women, the IUS offers desirable method characteristics that differ from those of other options, even other long-acting reversible contraceptives.”
Comments